VJHemOnc is committed to improving our service to you

IMW 2019 | Determining the prognostic significance of upfront radiation therapy in MM

VJHemOnc is committed to improving our service to you

Peter Barth

Peter Barth, MD, of Brown University, Providence, RI, explains the rationale behind his research into the prognostic significance of upfront radiation therapy in multiple myeloma (MM). This was discussed at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter